Kevin A. David

2.5k total citations
41 papers, 1.2k citations indexed

About

Kevin A. David is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kevin A. David has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 17 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kevin A. David's work include Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Kevin A. David is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Kevin A. David collaborates with scholars based in United States, United Kingdom and Germany. Kevin A. David's co-authors include David M. Nanus, Matthew I. Milowsky, Peter R. Carroll, Andrew M. Evens, Jamie Ritchey, Leo I. Gordon, Joel Picus, Lauren Mauro, Sheila Prachand and Savita Bhalla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Kevin A. David

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin A. David United States 16 660 417 317 225 188 41 1.2k
Apostolos Kontzias United States 15 355 0.5× 117 0.3× 127 0.4× 295 1.3× 409 2.2× 31 1.3k
Martha Donoghue United States 16 696 1.1× 163 0.4× 154 0.5× 247 1.1× 157 0.8× 27 1.2k
Preston D. Steen United States 18 579 0.9× 125 0.3× 120 0.4× 259 1.2× 72 0.4× 47 1.0k
Lara Pijuán Spain 20 571 0.9× 129 0.3× 168 0.5× 307 1.4× 105 0.6× 74 1.3k
Monika Joshi United States 17 489 0.7× 61 0.1× 627 2.0× 360 1.6× 136 0.7× 85 1.2k
Yunsuk Choi South Korea 18 444 0.7× 146 0.4× 90 0.3× 339 1.5× 136 0.7× 101 1.1k
Aurélien Gobert France 8 869 1.3× 58 0.1× 143 0.5× 235 1.0× 133 0.7× 20 1.2k
L.L. Siu Canada 10 833 1.3× 86 0.2× 247 0.8× 248 1.1× 179 1.0× 30 1.1k
Hiroshi Ariyama Japan 20 804 1.2× 98 0.2× 259 0.8× 426 1.9× 280 1.5× 84 1.4k
E.D. Kreuser Germany 18 797 1.2× 207 0.5× 212 0.7× 202 0.9× 97 0.5× 48 1.2k

Countries citing papers authored by Kevin A. David

Since Specialization
Citations

This map shows the geographic impact of Kevin A. David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. David more than expected).

Fields of papers citing papers by Kevin A. David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. David. The network helps show where Kevin A. David may publish in the future.

Co-authorship network of co-authors of Kevin A. David

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. David. A scholar is included among the top collaborators of Kevin A. David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. David. Kevin A. David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ravi, Dashnamoorthy, Afshin Beheshti, Nasséra Abermil, et al.. (2021). Oncogenic Integration of Nucleotide Metabolism via Fatty Acid Synthase in Non-Hodgkin Lymphoma. Frontiers in Oncology. 11. 725137–725137. 11 indexed citations
3.
Shih, Weichung Joe, et al.. (2020). Impact of Insurance Status on Survival Outcomes in Adults With Acute Lymphoblastic Leukemia (ALL): A Single-center Experience. Clinical Lymphoma Myeloma & Leukemia. 20(11). e890–e896. 7 indexed citations
4.
Diefenbach, Catherine, Fangxin Hong, Richard F. Ambinder, et al.. (2020). Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial. The Lancet Haematology. 7(9). e660–e670. 97 indexed citations
5.
David, Kevin A., et al.. (2020). Current Treatment Options for Older Patients with Hodgkin Lymphoma. Current Treatment Options in Oncology. 21(5). 42–42. 9 indexed citations
6.
Katz, Deborah A., Michael P. Chu, Kevin A. David, et al.. (2019). Open-Label, Phase 2 Study of Blinatumomab after First-Line Rituximab-Chemotherapy in Adults with Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma. Blood. 134(Supplement_1). 4077–4077. 20 indexed citations
7.
Ravi, Dashnamoorthy, Saheli Sarkar, Sneha Purvey, et al.. (2019). Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma. Leukemia. 34(5). 1291–1304. 32 indexed citations
8.
David, Kevin A., Athena Kritharis, & Andrew M. Evens. (2018). Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?. The Lancet Haematology. 5(5). e186–e187. 1 indexed citations
9.
10.
David, Kevin A., et al.. (2017). The enteric toxicity of gluten enhances graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Medical Hypotheses. 104. 174–177. 1 indexed citations
11.
David, Kevin A., Dennis Cooper, & Roger Strair. (2017). Clinical Studies in Hematologic Microtransplantation. Current Hematologic Malignancy Reports. 12(1). 51–60. 10 indexed citations
12.
David, Kevin A., Nigel P. Mongan, Christopher P. Smith, Lorraine J. Gudas, & David M. Nanus. (2010). Phase I trial of ATRA-IV and depakote in patients with advanced solid tumor malignancies. Cancer Biology & Therapy. 9(9). 678–684. 21 indexed citations
13.
Evens, Andrew M., Kevin A. David, Irene Helenowski, et al.. (2010). Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era. Journal of Clinical Oncology. 28(6). 1038–1046. 229 indexed citations
14.
Bhalla, Savita, Sriram Balasubramanian, Kevin A. David, et al.. (2009). PCI-24781 Induces Caspase and Reactive Oxygen Species–Dependent Apoptosis Through NF-κB Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells. Clinical Cancer Research. 15(10). 3354–3365. 82 indexed citations
15.
David, Kevin A., Katherine Mallin, Matthew I. Milowsky, et al.. (2009). Surveillance of urothelial carcinoma. Cancer. 115(7). 1435–1447. 53 indexed citations
16.
Joshi, Sonali, Surinder Kaur, Amanda J. Redig, et al.. (2009). Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses. Proceedings of the National Academy of Sciences. 106(29). 12097–12102. 63 indexed citations
17.
David, Kevin A., Lauren Mauro, & Andrew M. Evens. (2007). Relapsed and Refractory Hodgkin Lymphoma: Transplantation Strategies and Novel Therapeutic Options. Current Treatment Options in Oncology. 8(5). 352–374. 11 indexed citations
18.
David, Kevin A., Matthew I. Milowsky, Lale Kostakoğlu, et al.. (2006). Clinical Utility of Radiolabeled Monoclonal Antibodies in Prostate Cancer. Clinical Genitourinary Cancer. 4(4). 249–256. 15 indexed citations
19.
Knesebeck, Olaf von dem, et al.. (2006). Aktives Altern und Lebensqualität. Zeitschrift für Gerontologie und Geriatrie. 39(2). 82–89. 4 indexed citations
20.
David, Kevin A., Matthew I. Milowsky, & David M. Nanus. (2006). Chemotherapy for Non–Clear-Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer. 4(4). 263–268. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Apostolos Kontzias Breakdown of academic impact, for papers by Martha Donoghue Breakdown of academic impact, for papers by Preston D. Steen Breakdown of academic impact, for papers by Lara Pijuán Breakdown of academic impact, for papers by Monika Joshi Breakdown of academic impact, for papers by Yunsuk Choi Breakdown of academic impact, for papers by Aurélien Gobert Breakdown of academic impact, for papers by L.L. Siu Breakdown of academic impact, for papers by Hiroshi Ariyama Breakdown of academic impact, for papers by E.D. Kreuser
Rankless by CCL
2026